Sundry Photography/iStock Editorial via Getty Images Shockwave Medical ( NASDAQ: SWAV ) rose 1.3% in after hours trading after the HSR waiting period for its planned sale to Johnson & Johnson ( JNJ ) expired. The HSR waiting period expired on Monday, according to an 8-K filing on Tuesday.
The expiration of the waiting period satisfies one of the conditions for the closing of the transaction. Shockwave ( SWAV ) holders are scheduled to vote on the deal next Wednesday. Early last month, Johnson & Johnson ( JNJ ) agreed to acquire Shockwave ( SWAV ) for $335.
00 per share in cash, indicating roughly $13.1B in enterprise value for the cardiovascular device maker. More on ShockWave Medical Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors Why Shockwave Medical Stands Out In The Medical Device Sector Shockwave Medical Q4 Earnings Recap: Plenty Of Reasons To Stay Bullish ShockWave Medical GAAP EPS of $1.
44 beats by $0.47, revenue of $218.8M beats by $11.
15M ShockWave Medical Q1 2024 Earnings Preview.
